# BridgeBio Pharma, Inc. (BBIO) vs State Street SPDR S&P 500 ETF Trust (SPY) · total-return overlay

LOPJLB holding-return compare (5Y). Dividends and splits. Each path starts at 0% from the first adjusted close in the window.

BridgeBio Pharma, Inc. (BBIO) vs State Street SPDR S&P 500 ETF Trust (SPY) total return over 5Y: BBIO +40.12%, SPY +91.57%. Regime BBIO RECOVERY · SPY BULL. As of Oct 9, 2026. Research only.

- Interactive: https://www.lopjlb.com/vs/BBIO/SPY
- API: `GET /bff/api/bigfive/compare-series?symbols=BBIO%2CSPY&range=5y`

## Window

| Symbol | Window % | Worst drawdown | YTD |
|---|---:|---:|---:|
| BBIO | +40.12% | -90.25% | -16.47% |
| SPY | +91.57% | -24.49% | +14.86% |

## Periods (calendar lookback)

| Symbol | 1Y | 2Y | 3Y | 5Y |
|---|---:|---:|---:|---:|
| BBIO | +19.27% | +179.51% | +155.17% | +40.12% |
| SPY | +17.26% | +38.01% | +86.77% | +91.57% |

## Annual

| Year | BBIO | SPY |
|---|---:|---:|
| YTD | -16.47% | +14.86% |
| 2025 | +171.24% | +18.01% |
| 2024 | -32.16% | +25.59% |
| 2023 | +463.04% | +26.73% |
| 2022 | -55.59% | -18.64% |
| 2021 | -64.24% | +9.65% |

---

Research context only. Not personalized investment advice.